| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |